79. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Donnerstag, 4. April 2013 (Saal 15) 16:00-17:30

Freie Vorträge

TAVI – Devices

Vorsitz: G. Lutter (Kiel), U. Schäfer (Hamburg)

(V858) Single-center experience using second generation devices for transapical transcatheter aortic valve implantation

H. Treede, L. Conradi, M. Seiffert, R. Schnabel, J. Schirmer, D. Koschyk, S. Baldus, H. Reichenspurner, S. Blankenberg, P. Diemert (Hamburg, Köln)
(V859) The Impact of Post-implant SAPIEN XT Geometry and Position on Conduction Disturbances, Hemodynamic Performance and Paravalvular Regurgitation

R. Binder, J. G. Webb, S. Toggweiler, M. Freeman, M. Barbanti, A. B. Willson, D. Alhassan, C. J. Hague, D. Wood, J. Leipsic (Vancouver, CA)
(V860) Implantation of a JenaValve transcatheter heart valve in a series of patients with pure aortic regurgitation

M. Seiffert, D. Koschyk, J. Schirmer, R. Schnabel, L. Conradi, H. Reichenspurner, S. Blankenberg, H. Treede, P. Diemert (Hamburg)
(V861) Evaluation of the next generation SAPIEN XT transcatheter heart valve (THV) and delivery system. Data from the PREVAIL TF (EU) trial.

S. Sack, J. Menne, A. Vahanian, A. Cribier, B. DeBruyne, T. Lefevre, M. Thomas, J. Fajadet, G. C. Schuler, D. MacCarthy, J. Schofer, G. Schymik (München, Leipzig, Hamburg, Karlsruhe; Paris, Rouen, Massy, Toulouse, FR; Aalst, BE; London, UK)
(V862) Long-term performance of a nonmetallic, retrievable and repositionable aortic valve in patients with severe aortic stenosis
4 Year Follow-Up of the 22 F-Direct Flow Medical Valve

K. Bijuklic, T. Tübler, H. Reichenspurner, H. Treede, R. Low, E. Grube, J. Schofer (Hamburg, Bonn; Sacramento, US)
(V863) Protektion der Koronararterien bei der Behandlung degenerierter Mitroflow-Prothesen mittels Transkatheter Aortenklappen „valve in valve“-Implantation.

J. C. Horstkotte, R. Müller, P. Boekstegers (Siegburg)